Welcome to eBioscience. Tel: 888.999.1371 or 858.642.2058.  San Diego, California, USA.
View cart
Account
Ordering help
MSDS
Home Products Protocols Technical Support About Us Contact Us
PE anti-human DR5 (CD262, Trail-R2, TrailR2)
 
Print Page  
 
Adobe PDF    Human Cellular Antigens Chart
Contents: PE anti-human DR5 (CD262, Trail-R2, TrailR2)
Catalog Number: 12-9908
Formulation: Phosphate buffer pH 7.2,
150 mM NaCl, 0.09% NaN3, 0.2% BSA
Storage Conditions: Store at 4°C.
DO NOT FREEZE.
LIGHT-SENSITIVE MATERIAL.
Clone: DJR2-4 (a.k.a. 7-8)
Isotype: Mouse IgG1, κ

Prices for This Product*
Cat. No. Size Price Qty Action
12-9908-71 25 tests $150
12-9908-73 100 tests $290
*International customers: Please contact your distributor for region specific pricing.

   
data image 1
Surface staining of human DR5 transfected cells with anti-human DR5 (DJR2-4) PE. Appropriate isotype controls were used (open histogram). Total viable cells were used for analysis.
Available Formats of This Product
Cat. No. Format Excite
(nm)
Emit
(nm)
Reported Applications
12-9908 PE anti-human DR5 (CD262, Trail-R2, TrailR2) 488 575 FC 
13-9908 Biotin anti-human DR5 (CD262, Trail-R2, TrailR2) N/A N/A FC 
14-9908 Affinity Purified anti-human DR5 (CD262, Trail-R2, TrailR2) N/A N/A FC 

Questions? Please consult our answers to frequently asked questions at http://www.ebioscience.com/faq.


Description


The DJR2-4 monoclonal antibody reacts with human DR5, also known as TRAIL-R2, Apo2, TRICK2 and KILLER. DR5 binds to TRAIL, activates NF-κB, and induces TRAIL-mediated apoptosis. DR5 is expressed broadly by normal tissues as well as several tumor cells.


Applications Reported


For research use only, not for diagnostic or therapeutic use. The DJR2-4 (a.k.a. 7-8) antibody has been reported for use in flow cytometric analysis.


Applications Tested


The DJR2-4 (a.k.a. 7-8) antibody has been pre-titrated and tested by flow cytometric analysis of human peripheral blood leukocytes. This can be used at 20 μl (0.25 μg) per 100 μl blood (or per 1 million cells in 100 μl total staining volume).


References


Earel JK Jr, Vanoosten RL, Griffith TS. Histone deacetylase inhibitors modulate the sensitivity of tumor necrosis factor-related apoptosis-inducing ligand-resistant bladder tumor cells. Cancer Res. 2006 Jan 1;66(1):499-507. (FC, PubMed)




Related Products


Cat. 12-4714    Phycoerythrin (PE) Mouse IgG1, K Isotype Control
Cat. 14-9909    Affinity Purified anti-human DR5 (CD262, Trail-R2, TrailR2) (clone DJR2-2 (a.k.a. 2-6))


Home  |   Index  |   Site Map  |   FAQ  |   Terms & Conditions  |   Distributors  |   Careers  |   Contact Us
Copyright © 2000-2008 eBioscience, Inc.
Product For Research Use Only: Not for further distribution without written consent.